BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33066343)

  • 1. A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool.
    Todorov G; Uversky VN
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
    Alsulaiman JW; Khasawneh AI; Kheirallah KA
    J Infect Dev Ctries; 2020 Sep; 14(9):957-962. PubMed ID: 33031080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COVID-19 vaccine development landscape.
    Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S
    Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591
    [No Abstract]   [Full Text] [Related]  

  • 8. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
    Gaebler C; Nussenzweig MC
    Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid COVID-19 vaccine development.
    Graham BS
    Science; 2020 May; 368(6494):945-946. PubMed ID: 32385100
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID vaccine excitement builds as Moderna reports third positive result.
    Callaway E
    Nature; 2020 Nov; 587(7834):337-338. PubMed ID: 33199901
    [No Abstract]   [Full Text] [Related]  

  • 12. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding COVID-19 vaccine efficacy.
    Lipsitch M; Dean NE
    Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
    [No Abstract]   [Full Text] [Related]  

  • 15. The race for coronavirus vaccines: a graphical guide.
    Callaway E
    Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 shot protects monkeys.
    Cohen J
    Science; 2020 May; 368(6490):456-457. PubMed ID: 32355008
    [No Abstract]   [Full Text] [Related]  

  • 17. Status of COVID-19 vaccine development.
    Taxt AM; Grødeland G; Lind A; Müller F
    Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
    Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
    Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using
    Zayed H
    Front Immunol; 2020; 11():2051. PubMed ID: 32922408
    [No Abstract]   [Full Text] [Related]  

  • 20. Audio Interview: Vaccinology and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(16):e109. PubMed ID: 33053301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.